Costa Rica vs Finland: Prevalence of anemia among women of reproductive age
Costa Rica
13.7%
in 2023
Finland
13.6%
in 2023
Costa Rica rank
184th
Finland rank
185th
Prevalence of anemia among women of reproductive age over time
- Costa Rica
- Finland
How they compare
Costa Rica currently reports 13.7% against 13.6% in Finland, a difference of 0.1%.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Costa Rica ahead.
Costa Rica ranks 184th and Finland ranks 185th of 192 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Finland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.9% | 8.6% | 4.3% | Costa Rica |
| 2010s | 10.6% | 10.1% | 0.5% | Costa Rica |
| 2020s | 12.8% | 12.7% | 0.1% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, Costa Rica or Finland?
- Costa Rica, at 13.7% against 13.6% in Finland as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between Costa Rica and Finland?
- 0.1%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Finland?
- 24 years are reported by both, from 2000 to 2023.
- How do Costa Rica and Finland rank globally for prevalence of anemia among women of reproductive age?
- Costa Rica ranks 184th and Finland ranks 185th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.